{"Ticker": "DGX", "Company": "Quest Diagnostics", "Sector": "Health Care", "Updated": "2022-02-23", "Rating": [{"Date": "2022-02-23", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$160 to $139"}, {"Date": "2022-02-02", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$135"}, {"Date": "2022-01-28", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$190 to $129"}, {"Date": "2021-05-04", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$135 to $158"}, {"Date": "2021-03-12", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$137"}, {"Date": "2020-10-21", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2020-07-29", "Rating": "Upgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Overweight", "Target_Change": "$144"}, {"Date": "2020-07-14", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$142"}, {"Date": "2020-06-09", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$90 to $120"}, {"Date": "2020-06-02", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$140"}, {"Date": "2020-04-28", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$139"}, {"Date": "2020-04-27", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Underperform to Peer Perform", "Target_Change": ""}, {"Date": "2020-04-27", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$113 to $130"}, {"Date": "2020-03-27", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$95"}, {"Date": "2020-01-08", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": "$100"}, {"Date": "2020-01-07", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$106"}, {"Date": "2019-12-19", "Rating": "Upgrade", "Organization": "BofA/Merrill", "Rating_Change": "Underperform to Neutral", "Target_Change": "$94 to $110"}, {"Date": "2019-07-15", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$90 to $85"}, {"Date": "2019-04-02", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$93 to $107"}, {"Date": "2019-03-18", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$101 to $91"}, {"Date": "2019-01-31", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2019-01-17", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$90"}, {"Date": "2019-01-03", "Rating": "Downgrade", "Organization": "BofA/Merrill", "Rating_Change": "Neutral to Underperform", "Target_Change": ""}]}